These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32869914)

  • 1. Mesenchymal stem cells transplantation in systemic lupus erythematosus treatment.
    Huang X; Xu M; Li L; Zeng K
    Dermatol Ther; 2020 Nov; 33(6):e14262. PubMed ID: 32869914
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesenchymal stem cells transplantation for systemic lupus erythematosus.
    Liang J; Sun L
    Int J Rheum Dis; 2015 Feb; 18(2):164-71. PubMed ID: 25611801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
    Xu J
    Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus.
    Xu J; Lian W; Wu H; Wang X; Chen J; Yang L; Zhuang X; Li L; Huang Z
    Cell Mol Immunol; 2020 Oct; 17(10):1104-1106. PubMed ID: 32024977
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.
    Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L
    Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
    Zhu Y; Feng X
    Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
    Liu S; Guo YL; Yang JY; Wang W; Xu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.
    Liu F; Chen H; Chen T; Lau CS; Yu FX; Chen K; Chen HP; Pan RS; Chan GC; Zhang XY; Nie YJ
    Lupus; 2020 Jul; 29(8):872-883. PubMed ID: 32580680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study.
    Liang J; Zhang H; Hua B; Wang H; Lu L; Shi S; Hou Y; Zeng X; Gilkeson GS; Sun L
    Ann Rheum Dis; 2010 Aug; 69(8):1423-9. PubMed ID: 20650877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus--where are we now?
    Collins E; Gilkeson G
    Clin Immunol; 2013 Sep; 148(3):328-34. PubMed ID: 23411031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
    Zhang H; Zeng X; Sun L
    Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
    Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
    Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
    Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
    Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Fas
    Lee JH; Lee HK; Kim HS; Kim JS; Ji AY; Lee JS; Kim KS; Lee TY; Bae SC; Kim Y; Hong JT; Han SB
    Lupus; 2018 Oct; 27(11):1854-1859. PubMed ID: 30139297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus.
    Zheng B; Zhang P; Yuan L; Chhetri RK; Guo Y; Deng D
    Lupus; 2020 Feb; 29(2):126-135. PubMed ID: 31870216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.
    Wu KH; Cheng CC; Li JP; Weng TF; Yang SF; Pan HH; Chao YH
    Lupus; 2020 Feb; 29(2):165-175. PubMed ID: 31964222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell therapy induces FLT3L and CD1c
    Yuan X; Qin X; Wang D; Zhang Z; Tang X; Gao X; Chen W; Sun L
    Nat Commun; 2019 Jun; 10(1):2498. PubMed ID: 31175312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesenchymal stem cell treatment in autoimmune diseases].
    Keyßer G
    Z Rheumatol; 2020 Jun; 79(5):437-445. PubMed ID: 32322976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in mesenchymal stem cells: the key to decoding systemic lupus erythematosus.
    Geng L; Sun L
    Cell Mol Immunol; 2021 Sep; 18(9):2286-2287. PubMed ID: 34321620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.